Thoracic Specimen Registry

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT04118660
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Tissue Banking — OTHER
    Blood, tissue, and fluid collection

Study Details

The purpose of the registry will be to support ongoing research in the etiology, early diagnosis, clinical management, and prognosis of lung cancer and other cancers and diseases of the thorax by developing a complete repository of specimens from patients with thoracic disease including but not limited to suspected lung cancer, mediastinal and pleural tumors, lung transplants and from patients at a very high risk of developing other thoracic cancers or other thoracic diseases.

Key Dates

Start date
Mar 1, 2017
Status verified
Jan 2026
Primary completion
Jan 31, 2028
Completion
Jan 31, 2028

Study Design

Enrollment
7,000 participants (estimated)

Arms

  • Arm: Thoracic Disease
    Thoracic Diseases (which includes but not limited to the following: thoracic neoplasms (masses/nodules) malignant or benign, interstitial lung diseases (ILD), chronic obstructive pulmonary disease (COPD), thoracic infections, thoracic malignancies metastatic to other organs, other cancers metastatic to the thoracic cavity.

Primary Outcome Measure

Thoracic Specimen Repository [ Time Frame: Through study completion, approximately 10 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in RochesterRochesterMinnesota55905
Aaron Bungum
[email protected]
507-266-0078
Eric Edell, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
Mayo Clinic in Rochester· Rochester, MN

Related Studies